[Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside]

Rinsho Ketsueki. 1995 Jan;36(1):56-8.
[Article in Japanese]

Abstract

A 74-year-old woman was admitted in October 1988 with anemia and leukocytopenia. Hematologic investigations established a diagnosis of hypoplastic acute leukemia. She received a low dose of cytosine arabinoside (LDAC: 10 mg/m2 every 12 hours) subcutaneously for 21 days and achieved complete remission (CR) one month later. After one course of LDAC of 14 days, she received LDAC of 21 days every 5 to 6 months as maintenance therapy till April 1993. She has been in remission for 6 years. Intensification therapy with LDAC every 5 to 6 months might be useful in maintaining remission for hypoplastic acute leukemia.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Anemia / complications
  • Cytarabine / administration & dosage*
  • Female
  • Humans
  • Leukemia / drug therapy*
  • Leukopenia / complications
  • Remission Induction

Substances

  • Cytarabine